Efficacy of axitinib rechallenge in metastatic renal cell carcinoma

Int J Urol. 2021 Jun;28(6):702-703. doi: 10.1111/iju.14529. Epub 2021 Mar 14.
No abstract available

MeSH terms

  • Antineoplastic Agents* / therapeutic use
  • Axitinib / adverse effects
  • Carcinoma, Renal Cell* / drug therapy
  • Humans
  • Indazoles / adverse effects
  • Kidney Neoplasms* / drug therapy
  • Protein Kinase Inhibitors / adverse effects
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Indazoles
  • Protein Kinase Inhibitors
  • Axitinib